Fig. 1From: Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniaeAlamar blue assay for bacterial viability assessment. There was no change in the fluorescence intensity between both coumarin-treated and untreated bacteriaBack to article page